Angry@Arthritis

A 501(c)(3) focused on attacking osteoarthritis

[Angry@Arthritis @angryarthritis]

🦴 RT "@ArthritisDigest A new blood test can find knee osteoarthritis up to eight years before it appears on X-ray https://t.co/jae5JR8viB #KneeArthritis #KneePain #OsteoArthritis #ArthritisDiagnosis #ArthritisDigest #GameChanger"

[Orthopedic Design & Technology @ODTmagazine]

ODT's top headlines of 2023: #8 | @angryarthritis https://t.co/q6QevqI2uA

[Angry@Arthritis @angryarthritis]

Get ready for the next Angry@Arthritis #podcast episode, where we’ll sit down with more #osteoarthritis experts to get closer to finding a cure 🧪: https://t.co/AoIPS3E9AU

[Angry@Arthritis @angryarthritis]

“Cartilage and other tissues, which are found in knee joints, are the same tissues which can be found in, for example, hip or other articulating joints. So in other words, it's a fair assumption to say that R399E could work in all joints where injections can be conducted.”

In this Angry@Arthritis #podcast episode, listen to Dr. Martin Michaelis deep dive into the potential of R399E, a potential #OA treatment 🎙️: https://t.co/dHMCGKNNKU

[Angry@Arthritis @angryarthritis]

Did you know? 🦴 Check out these facts on R399E, a potential new treatment for #osteoarthritis:

https://t.co/tEMH1AOzz3

[Angry@Arthritis @angryarthritis]

In the 9th Angry@Arthritis #podcast episode, we cover:

1️⃣ Dr. Martin Michaelis’ work in the field of #OA
2️⃣ R399E, one of the drugs from Merck KGaA, to help reduce pain and slow the progression of #osteoarthritis
3️⃣ The history of where the drug came from and and the path forward from here

Listen to hear more: https://t.co/dHMCGKNNKU

[Angry@Arthritis @angryarthritis]

“R399E has the promise for [osteoarthritis] patients, first, to reduce pain with a very quick onset within hours after the first injection of R3998 into knee joints, and secondly, in the long-term, R3900 holds the promise to at least slow down the progression of osteoarthritis.”

🩺 Check out the latest Angry@Arthritis #podcast episode to hear more from Dr. Martin Michaelis about this potential #OA cure: https://t.co/dHMCGKNNKU

[Angry@Arthritis @angryarthritis]

In our latest #podcast episode, Dr. Martin Michaelis discusses a potential new treatment for #osteoarthritis called R399E 🎧 Tune in:

https://t.co/tEMH1AOzz3

[Angry@Arthritis @angryarthritis]

The next Angry@Arthritis #podcast episode is now live. Tune in to hear:

➡️ Dr. Martin Michaelis, former head of osteoarthritis research and early clinical development, talk about his work in the field
➡️ Discussion of a potential new treatment for OA called R399E
➡️ The history of similar drugs and what’s next for OA treatments

https://t.co/dHMCGKNNKU

[Angry@Arthritis @angryarthritis]

The @UniBasel_en has achieved a milestone by developing the first biological implants for treating cartilage lesions and #osteoarthritis in humans.

These implants represent a significant advancement in addressing these conditions. Read more from Scienmag: https://t.co/26Ro2ymleZ

#clinicaltrials #treatment #research

[Angry@Arthritis @angryarthritis]

The @DepBiomedicine at @UniBasel_en announced that it delivered the first surgical procedure to treat #osteoarthritis in humans, called Nasal Chondrocyte Tissue-Engineered Cartilage, or N-TEC. Read for more details: https://t.co/M89wy1EoA9

[Angry@Arthritis @angryarthritis]

This #WorldArthritisDay, let's work together to provide arthritis and #OA patients real insights on the state of the science and emerging cures.

Angry@Arthritis is a 501(c)(3) not-for-profit focused on attacking #osteoarthritis. Learn more about our mission here: https://t.co/oTGsC04ImE

[Angry@Arthritis @angryarthritis]

Get ready for the next Angry@Arthritis #podcast episode, where we’ll sit down with more #osteoarthritis experts to get closer to finding a cure 🧪: https://t.co/AoIPS3E9AU

[Angry@Arthritis @angryarthritis]

“No matter how hard you push the gas pedal, you're not going to move forward [if your foot is on the brake]. We really need to think of balance.”

In this Angry@Arthritis #podcast episode, listen to Dr. @JHElisseeff, professor and director of the Translational Tissue Engineering Center at @JohnsHopkins, deep dive into the future of #OA cures 🎙️: https://t.co/4bPngNpkWr

[Angry@Arthritis @angryarthritis]

Did you know? 🦴 Check out these facts on #regenerative #immunology and hear from @JohnsHopkins’ Dr. @JHElisseeff in our newest podcast episode: https://t.co/EW2UP5V3SY

[Angry@Arthritis @angryarthritis]

In the 8th Angry@Arthritis #podcast episode, we cover:

1️⃣ @JohnsHopkins’ Dr. @JHElisseeff’s work in the field of #OA
2️⃣ How regenerative immunology is causing a major shift in the research
3️⃣ Possible new cures using #senolytics and antiaging therapies

Listen to hear more: https://t.co/4bPngNpkWr

[Angry@Arthritis @angryarthritis]

“I think one of the questions that people who are listening to this podcast are asking, because they've got osteoarthritis or they know somebody that has osteoarthritis, is where are we in the journey to taking this stuff from the labs into the clinic and actually helping people?”

🩺 Check out the latest Angry@Arthritis #podcast episode to hear more from @JohnsHopkins’ Dr. @JHElisseeff on the journey to an #OA cure: https://t.co/4bPngNpkWr

[Angry@Arthritis @angryarthritis]

In our latest #podcast episode, @JohnsHopkins’ Dr. @JHElisseeff discusses the emerging science in #regenerative immunology – exploring how the body can heal itself. 🎧 Tune in: https://t.co/EW2UP5Uw3q

[Angry@Arthritis @angryarthritis]

The next Angry@Arthritis #podcast episode is now live. Tune in to hear:

➡️ Dr. @JHElisseeff, professor and director of the Translational Tissue Engineering Center at @JohnsHopkins, discuss the leading #bioscience in OA cures
➡️ Trials for growing #cartilage and the concept of regenerative immunology
➡️ How the field of #senolytics and antiaging therapies may help

https://t.co/4bPngNpkWr

[Angry@Arthritis @angryarthritis]

The U.S. government has unveiled the NITRO program, which plans to cure OA in five years. But can it really be done?

Rumored to be funded at $1 billion and launched out of the new Advanced Research Project Agency for Health (ARPA-H), the Novel Innovations for Tissue Regeneration in Osteoarthritis, or NITRO program, focuses on three categories of cure to regenerate bone, cartilage, and create organic joint replacement.

Read about this and more at Clinical Leader: https://t.co/KFkSD0arbB

#osteoarthritis #clinicaltrials #treatment #research